retatrutide triple hormone receptor agonist benefits Diagram showing the mechanism of action of Lilly's triple agonist achieves 16.8%

Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists form classes of medicines that can help treat conditions such as type 2 diabetes and obesity

Experts classify GLP-1 receptor agonists into two types: human GLP-1 backbone agents (e.g., Liraglutide, Dulaglutide, Semaglutide) and exendin-4 backbone agents (e.g., exenatide) (23)

self-inject daily Note: Wegovy and Zepbound are the only options here FDA-approved for weight loss

Ther Adv Musculoskeletal Dis

GLP-1 Patches Brand Comparison Table: In stark contrast, clinically proven FDA-approved GLP-1 injections demonstrate substantial effectiveness

Its mechanism is broader, its attention curve is steeper, and its data has made a much louder impact